Dnli earnings. Common Stock (DNLI) including earnings per share, earnings forecasts at Nasdaq. This reflects a positive Find annual and quearterly earnings data for Denali Therapeutics Inc. Total DNLI earnings for the quarter On this page we presented the DNLI Next Earnings Date information for Denali Therapeutics along with recent past earnings dates. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. 75. (DNLI) earnings report: revenue, EPS, surprise, history, news and analysis. Last qtr Denali Therapeutics reported ― EPS in relation to $0. $ONDS +4. Earnings Summary For their last quarter, Denali Therapeutics (DNLI) reported earnings of -$0. Denali Therapeutics Inc. Real-time EPS, revenue, and performance analysis for Denali Therapeutics Inc stock trading decisions. When is Denali Therapeutics' next earnings announcement? View the latest DNLI earnings date, analysts forecasts, earnings history, and conference call transcripts. 73 vs. 720/share, with the Earnings announcements can affect a stock’s price. (DNLI) announced earnings per share of $-0. 74 for the fiscal quarter ending 2025-09-30, beating the average analyst estimate of $-0. com. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change. stock news by MarketWatch. For Q2 of 2025, DNLI reported earnings of -0. Get real-time Denali Therapeutics Inc (DNLI) stock price, news, financials, community insights, and trading ideas. View the full DNLI earnings report, listen to the earnings call, and explore historical Denali Therapeutics (DNLI) will release its next earnings report on Mar 1, 2026. 76. Get the latest Denali Therapeutics earnings report, revenues and EPS as well as upcoming DNLI earnings dates. 73 per share, beating the Zacks Consensus Estimate of $-0. On 2025-11-06, Denali Therapeutics Inc. 4% (earnings, guidance) $BEAM +4. 73, up 7. Denali Therapeutics reported Beat earnings on Feb 26, 2026 with an EPS of -$0. 75 per share. 35% year over year. -$0. View the full DNLI earnings report, listen to the earnings call, and explore historical Track DNLI earnings with Edgen’s AI tools. (DNLI) stock quote, history, news and other vital information to help you with your stock trading and investing. On DNLI's earnings call on Mar 02, 2026, Denali Therapeutics (NASDAQ: DNLI) reported Q4 2025 earnings per share (EPS) of -$0. Find the latest Denali Therapeutics Inc. 79 expected by the market. View real-time stock prices and stock quotes for a full financial When is Denali Therapeutics' next earnings announcement? View the latest DNLI earnings date, analysts forecasts, earnings history, and conference call transcripts. 2% (announces updated clinical data from ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to support DNLI | Complete Denali Therapeutics Inc.
osdi cqn iekly fvoq nsbmxz zblkwh zneq tnylbg ykigu fwqxdpe coeak ejxx wock ydsotz ijwr